Evidence map›Paper›PMID 31165962›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2019

Emergence of two novel sequence types (3366 and 3367) NDM-1- and OXA-48-co-producing K. pneumoniae in Italy.

Floriana Gona, Dafne Bongiorno, Ausilia Aprile, Erika Corazza, Betta Pasqua, Maria Grazia Scuderi, Matteo Chiacchiaretta, Daniela Maria Cirillo, Stefania Stefani, Maria Lina Mezzatesta

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Cell-free supernatant ofFrontiers in cellular and infection microbiology · 2024
    Article
  5. Outbreak of OXA-48-producing Enterobacteriaceae in a neonatal intensive care unit in Western Sweden.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2023
    Article
  6. Article
  7. Polyclonal Endemicity of Carbapenemase-ProducingAntibiotics (Basel, Switzerland) · 2022
    Article
  8. Omic insights into various ceftazidime-avibactam-resistantFrontiers in cellular and infection microbiology · 2022
    Article
  9. Article
  10. Article
  11. Co-Production of NDM-1, CTX-M-9 Family and mcr-1 in aInfection and drug resistance · 2021
    Article
  12. Article
  13. Article
  14. Extensively drug-resistantEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Floriana GonaEmerging Bacterial Pathogens Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Dafne BongiornoDepartment of Biomedical and Biotechnological Sciences, section of Microbiology, University of Catania, Via Santa Sofia n.97, 95123, Catania, Italy.
Ausilia AprileDepartment of Biomedical and Biotechnological Sciences, section of Microbiology, University of Catania, Via Santa Sofia n.97, 95123, Catania, Italy.
Erika CorazzaDepartment of Biomedical and Biotechnological Sciences, section of Microbiology, University of Catania, Via Santa Sofia n.97, 95123, Catania, Italy.
Betta PasquaU.O. "Policlinico-Vittorio Emanuele G.Rodolico", Catania, Italy.
Maria Grazia ScuderiU.O. "Policlinico-Vittorio Emanuele G.Rodolico", Catania, Italy.
Matteo ChiacchiarettaEmerging Bacterial Pathogens Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Daniela Maria CirilloEmerging Bacterial Pathogens Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Stefania StefaniDepartment of Biomedical and Biotechnological Sciences, section of Microbiology, University of Catania, Via Santa Sofia n.97, 95123, Catania, Italy.
Maria Lina MezzatestaDepartment of Biomedical and Biotechnological Sciences, section of Microbiology, University of Catania, Via Santa Sofia n.97, 95123, Catania, Italy. mezzate@unict.it.ORCID http://orcid.org/0000-0003-0853-9564

Funding

PRIN 2017 SFBFER
6 · The paper itself

Abstract

The aim of this study was to analyze the alarming spread of NDM-1- and OXA-48-co-producing Klebsiella pneumoniae clinical isolates, collected between October 2016 and January 2018 in a neonatal intensive care unit of the University Hospital, Catania, Italy, through whole genome sequencing. All confirmed carbapenem-resistant K. pneumoniae (CRKp) isolates were characterized pheno- and geno-typically, as well as by whole genome sequencing (WGS). A total of 13 CRKp isolates were identified from 13 patients. Pulsed-field gel electrophoresis (PFGE) was performed, and the multilocus sequence typing (MLST) scheme used was based on the gene sequence as published on the MLST Pasteur website. Core genome MLST (cgMLST) was also performed. All isolates co-carried bla

Indexed as

Anti-Bacterial AgentsBacterial ProteinsBacterial Typing Techniquesbeta-LactamasesCarbapenemsDisease OutbreaksElectrophoresis, Gel, Pulsed-FieldHumansInfant, NewbornIntensive Care, NeonatalItalyKlebsiella InfectionsKlebsiella pneumoniaeMicrobial Sensitivity TestsMultilocus Sequence TypingWhole Genome SequencingAnti-Bacterial AgentsBacterial Proteinsbeta-lactamase NDM-1beta-LactamasesCarbapenemsoxacillinaseCarbapenemaseK. pneumoniaeNDMOXA-48ST101ST3366ST3367

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.